MSD's etanercept, BRENZYS, will become the first biosimilar listed with new uptake drivers on 1 December. …
Latest Video
New Stories
-
A relationship that works for patients
January 18, 2019 - - Comment -
Pharmaxis updates on LOXL2 studies
January 18, 2019 - - Latest News -
Clock ticking as caretaker approaches
January 17, 2019 - - Latest News -
The genesis of the policy that continues to shape PBS discussions
January 17, 2019 - - Latest News -
Takeda rings the bell in New York
January 17, 2019 - - Latest News -
Novo Nordisk's Michala Fischer-Hansen returning to Denmark
January 17, 2019 - - Latest News -
CHF: End cost-offset rule
January 17, 2019 - - Latest News